Biocon Ltd receives EIR from USFDA with VAI status for Cranbury facility

Biocon Ltd has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration (US FDA), for our Biocon Generics Inc facility, located in Cranbury, New Jersey, U.S.

This is based on a cGMP inspection conducted by the agency between the 6th to 10th of October, 2025.

Shares of Biocon Limited was last trading in BSE at Rs. 392.15 as compared to the previous close of Rs. 386.40. The total number of shares traded during the day was 114610 in over 2947 trades.

The stock hit an intraday high of Rs. 395.35 and intraday low of 385.80. The net turnover during the day was Rs. 44939875.00.

Source : Equity Bulls

Keywords

Biocon INE376G01013 Biotechnology USFDA EIR VAIStatus